Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576276 · ClinicalTrials.gov registry record · NA
A Brain Imaging Study of Opioid (Morphine) and Non-opioid (Ketorolac) Conditioning Effects
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT01576276: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01576276 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01576276, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
Healthy right-handed volunteers aged 21 to 50 needed for a research study of the effects of morphine and ketorolac on brain activity in response to pain stimuli as measured by functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET). Study will be conducted on six separate days not requiring an overnight stay in the hospital.
Interventions
- DRUG Ketorolac
- RADIATION Integrated MR-PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-04 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576276
The ClinicalTrials.gov registry entry for NCT01576276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT01576276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01576276 about?
NCT01576276 is a clinical study titled "A Brain Imaging Study of Opioid (Morphine) and Non-opioid (Ketorolac) Conditioning Effects". Healthy right-handed volunteers aged 21 to 50 needed for a research study of the effects of morphine and ketorolac on brain activity in response to pain stimuli as measured by functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET). Study will be conducted on six separate...
What is the current status of trial NCT01576276?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2012-04. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01576276?
The interventions under investigation include: Ketorolac (DRUG), Integrated MR-PET scan (RADIATION).
Who is sponsoring clinical trial NCT01576276?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.